DALACIN-C

This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Estonia, Hong Kong, Croatia, Ireland, Israel, Italy, Lithuania, Malta, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, United Kingdom, South Africa

Active ingredients

The drug DALACIN-C contains one active pharmaceutical ingredient (API):

1 Clindamycin UNII 3U02EL437C - CLINDAMYCIN

Clindamycin is a lincosamide antibiotic with a primarily bacteriostatic action against Gram-positive aerobes and a wide range of anaerobic bacteria. Lincosamides such as clindamycin bind to the 50S subunit of the bacterial ribosome and inhibit the early stages of protein synthesis. Read about Clindamycin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
DALACIN C Capsule	Medicines and Medical Devices Safety Authority (NZ)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
D10AF01	Clindamycin	D Dermatologicals → D10 Anti-acne preparations → D10A Anti-acne preparations for topical use → D10AF Antiinfectives for treatment of acne
Discover more medicines within D10AF01
G01AA10	Clindamycin	G Genito urinary system and sex hormones → G01 Gynecological antiinfectives and antiseptics → G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS → G01AA Antibiotics
Discover more medicines within G01AA10
J01FF01	Clindamycin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01F Macrolides, lincosamides and streptogramins → J01FF Lincosamides
Discover more medicines within J01FF01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 3138E, 5057E
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 522718030075017
Country: CA	Health Products and Food Branch	Identifier(s): 00030570, 00225851, 00260436, 02060604, 02182866
Country: EE	Ravimiamet	Identifier(s): 1007503, 1007536, 1007569, 1068915, 1070008, 1070019, 1865101
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 142164, 185723, 36687, 36692, 39566, 43490, 78168
Country: HK	Department of Health Drug Office	Identifier(s): 00438, 00485
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-200113413
Country: IE	Health Products Regulatory Authority	Identifier(s): 19402, 19486, 19534, 19567, 84786
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 33, 3511, 7728
Country: IT	Agenzia del Farmaco	Identifier(s): 023868021
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1010488, 1010489, 1079258, 1079670, 1081829, 1092423
Country: MT	Medicines Authority	Identifier(s): MA505/01902, MA505/01903, MA505/01904, MA505/01905, PI1438/09701A, PI1513/01701A, PI908/12402A
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 76372, 84560, 84745
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 30430, 4685
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 1159, 1160
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100016908, 100016914, 100016920, 100016937, 100016943, 100450970, 100461382
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W65032001, W65033001
Country: SG	Health Sciences Authority	Identifier(s): 01502P, 02170P, 09496P
Country: ZA	Health Products Regulatory Authority	Identifier(s): C/20.1.1/1, F/20.1.1/169